| Literature DB >> 35837601 |
Byoung Hyuck Kim1,2, Jin Woo Jung3, Dohyun Han3,4, Myung-Jin Cha5, Ji Hyun Chang2.
Abstract
Background: Recently, stereotactic ablative radiotherapy (SABR) has been adopted to non-invasively treat catheter ablation-refractory ventricular tachycardia (VT). VT episodes have been dramatically reduced after SABR, within weeks; however the underlying mechanisms of these clinical effects and potential mediators of early anti-arrhythmic effect remain unclear.Entities:
Keywords: antiarrhythmic effects; cardiac conduction system; proteomics; radioablation; rats (all MESH terms)
Year: 2022 PMID: 35837601 PMCID: PMC9273889 DOI: 10.3389/fcvm.2022.898222
Source DB: PubMed Journal: Front Cardiovasc Med ISSN: 2297-055X
Figure 1The hierarchical clustering of differentially expressed cardiac proteome induced by single high-dose irradiation. (A) Overall ANOVA results at day 3 and day 7. The DEPs were filtered with P-value lower than 0.05 and Z-normalized for visualization. The result identified 1,489 and 1,283 DEPs at day 3 and day 7, respectively. The Venn diagram presented the 215 common DEPs. (B) PPI (protein-protein interaction) analysis of common DEPs, presented with functional enrichment (P-value <0.05) from GO analysis. The filled node presents protein expression from day 3 and the barrier of node presents protein expression from day 7. The list of identified functional process is also displayed as bar chart.
Figure 2KEGG pathway analysis of common DEPs between 3 and 7 days of dose group in irradiated rat. (A) The result of KEGG pathway analysis, filtered with FDR value lower than 0.05. Among those, the pathways that directly related with cardiovascular activity or associated disease are plotted, which are (B) Regulation of actin cytoskeleton, (C) VEGF signaling pathway, and (D) tuberculosis.
Figure 3ANOVA pattern clustering analysis of differentially expressed proteins related to dose group in irradiated rat. The hierarchical cluster was performed after ANOVA multiple comparison test between 0, 2, and 25 Gy at day 3 and day 7, respectively. The pre-process was implemented by unbiased K-means clustering. Among the defined clusters, we subdivide those to investigate the detailed pattern of proteome alterations related to dose of irradiation. The colorimetric scheme represented z-normalized intensity of DEPs. (A) Defined clusters that reveals specific expression pattern of DEPs at day 3 (P-value <0.05, 1,489 proteins). The clusters were divided with 2.245 threshold. The detailed clusters show the protein alteration patterns with specifically up-regulated in 2 Gy irradiation (pattern 1), gradually increasing according to increasing dose of irradiation (pattern 2 and 3), specifically up-regulated (pattern 4), and down-regulated in 25 Gy irradiation (pattern 5). (B) Defined clusters that reveals specific expression pattern of DEPs at day 7 (P-value <0.05, 1,283 proteins). The clusters were divided with 2.476 threshold. The detailed clusters show the protein alteration patterns with specifically up-regulated in 2 Gy irradiation (pattern 1), gradually increasing according to increasing dose of irradiation (pattern 2 and 3), specifically up-regulated (pattern 4), and down-regulated in 25 Gy irradiation (pattern 5).
Figure 4Protein expression comparison based on t-test between each different dose group and biological process of specifically expressed proteins at 25 Gy irradiation. (A) The hierarchical clustering of DEPs after t-test comparison between each group individually at day 3. The colorimetric scheme represented z-normalized intensity of DEPs. 49 DEPs between 0 and 2 Gy, 200 DEPs between 0 and 25 Gy, and 46 DEPs between 2 and 25 Gy. (B) The hierarchical clustering of DEPs after t-test comparison between each group individually at day 7. The colorimetric scheme represented z-normalized intensity of DEPs. 137 DEPs between 0 and 2 Gy, 166 DEPs between 0 and 25 Gy, and 68 DEPs between 2 and 25 Gy. (C) The 169 specifically expressed proteins at 25 Gy at day 3, determined by excluding DEPs between 0 and 25 Gy from DEPs between 0 and 25 Gy. The biological process of those were filtered with P-value lower than 0.05. The bar chart represent −(P - value) and spotted plot represent the number of proteins included in specific process. (D) The 133 specifically expressed proteins at 25 Gy at day 7, determined by excluding DEPs between 0 and 25 Gy from DEPs between 0 and 25 Gy. The biological process of those were filtered with P-value lower than 0.05. The bar chart represent −(P - value) and spotted plot represent the number of proteins included in specific process.
Complete list of validation target proteins.
|
|
|
|
|
| |
|---|---|---|---|---|---|
| 1 | Axin1 | O70239 | Axin-1 | 3 days | 25-Gy specific up |
| 2 | Ccl21 | Q5RJN3 | C-C motif chemokine ligand 21 | 3 days | 25-Gy specific up |
| 3 | Pdlim5 | Q62920-2 | Isoform 2 of PDZ and LIM domain protein 5 | 3 days | 25-Gy specific up |
| 4 | Rab3d | Q63942 | GTP-binding protein Rab-3D | 3 days | 25-Gy specific up |
| 5 | Gsta1 | B6DYP8 | Glutathione S-transferase | 7 days | 25-Gy specific up |
| 6 | rCG_21069 | D3ZCD6 | RCG21069 | 7 days | 25-Gy specific up |
| 7 | Slc27a3 | D3ZJA9 | Solute carrier family 27 (fatty acid transporter), member 3 (Predicted) | 7 days | 25-Gy specific up |
| 8 | Myot | D3ZTC5 | Myotilin | 7 days | 25-Gy specific up |
| 9 | Lig4 | D4A0U6 | DNA ligase | 7 days | 25-Gy specific up |
| 10 | Abcb1b | D4A0Y9 | ATP-binding cassette, subfamily B (MDR/TAP), member 1B | 7 days | 25-Gy specific up |
| 11 | Klhdc7a | M0R439 | Kelch domain-containing 7A | 7 days | 25-Gy specific up |
| 12 | Ephx1 | P07687 | Epoxide hydrolase 1 | 7 days | 25-Gy specific up |
| 13 | Mmp2 | P33436 | 72 kDa type IV collagenase | 7 days | 25-Gy specific up |
| 14 | Phlda3 | Q5PQT7 | Pleckstrin homology-like domain family A member 3 | 7 days | 25-Gy specific up |
| 15 | Capg | Q6AYC4 | Macrophage-capping protein | 7 days | 25-Gy specific up |
| 16 | Insig2 | Q80UA9 | Insulin-induced gene 2 protein | 7 days | 25-Gy specific up |
| 17 | Osbpl5 | A0A0G2JV78 | Oxysterol-binding protein | 7 days | 25-Gy specific down |
| 18 | Gtf3c3 | A0A0G2K945 | General transcription factor IIIC subunit 3 | 7 days | 25-Gy specific down |
| 19 | Mid1ip1 | A7BKC9 | MID1 interacting G12-like protein | 7 days | 25-Gy specific down |
| 20 | Glb1l | B1WBS6 | Galactosidase, beta 1-like | 7 days | 25-Gy specific down |
| 21 | Tyw5 | D3ZY75 | tRNA-yW synthesizing protein 5 | 7 days | 25-Gy specific down |
| 22 | Myorg | D4AE63 | Myogenesis-regulating glycosidase | 7 days | 25-Gy specific down |
| 23 | LOC690284 | F1LTK0 | Similar to F49E2.5d | 7 days | 25-Gy specific down |
| 24 | Kcnn3 | G3V8S7 | Potassium intermediate/small conductance calcium-activated channel, subfamily N, member 3, isoform CRA_a | 7 days | 25-Gy specific down |
| 25 | Ftl1 | P02793 | Ferritin light chain 1 | 7 days | 25-Gy specific down |
| 26 | Agap2 | Q8CGU4 | Arf-GAP with GTPase, ANK repeat and PH domain-containing protein 2 | 7 days | 25-Gy specific down |
| 27 | Sulf2 | Q3L472 | Extracellular sulfatase | 3 & 7 days | ANOVA 25-Gy specific up |
| 28 | Gas6 | Q63772 | Growth arrest-specific protein 6 | 3 & 7 days | ANOVA 25-Gy specific up |
| 29 | Tmem120a | Q5HZE2 | Transmembrane protein 120A | 3 & 7 days | ANOVA 25-Gy specific up |
| 30 | Rps27l | P24051 | 40S ribosomal protein S27-like | 3 & 7 days | ANOVA 25-Gy specific up |
| 31 | Wnt5a | Q9QXQ7 | Protein Wnt-5a | 7 days | |
| 32 | Kng1 | A0A0G2KA54 | Kininogen-1 | 7 days | |
| 33 | Kng1 | P08934 | Kininogen-1 | 7 days | |
| 34 | Cdkn1a | Q64315 | Cyclin-dependent kinase inhibitor 1A | 7 days | |
| 35 | Aqp1 | P29975 | Aquaporin-1 | 7 days | |
| 36 | Cd74 | P10247 | H-2 class II histocompatibility antigen gamma chain | 7 days | |
| 37 | Ryr2 | B0LPN4-2 | Isoform 2 of ryanodine receptor 2 | NA | Specific GO (cardiac conduction) |
| 38 | Cav1 | A2VCW2 | Caveolin (fragment) | NA | Specific GO (cardiac conduction) |
| 39 | Cacna2d2 | A0A0G2K0J2 | Voltage-dependent calcium channel subunit alpha-2/delta-2 | NA | Specific GO (cardiac conduction) |
| 40 | Gja3 | G3V747 | Gap junction protein | NA | Specific GO (cardiac conduction) |
| 41 | Scnb2 | Q62861 | Sodium channel beta 2 subunit | NA | Specific GO (cardiac conduction) |
| 42 | Atp2a1 | Q64578 | Sarcoplasmic/endoplasmic reticulum calcium ATPase 1 | NA | Specific GO (sarcoplasmic reticulum) |
| 43 | Camk2g | P11730 | Calcium/calmodulin-dependent protein kinase type II subunit gamma | NA | Specific GO (sarcoplasmic reticulum) |
| 44 | Actn1 | Q9Z1P2 | Alpha-actinin-1 | NA | Specific GO (intercalated disk) |
| 45 | Anxa5 | P14668 | Annexin A5 | NA | Specific GO (intercalated disk) |
| 46 | Scn4b | Q7M730 | Sodium channel subunit beta-4 | NA | Specific GO (intercalated disk) |
| 47 | Abca2 | G3V7X4 | ATP-binding cassette sub-family A member 2 | NA | Specific GO (vacuolar membrane) |
| 48 | Abcd1 | D3ZHR2 | ATP-binding cassette subfamily D member 1 | NA | Specific GO (vacuolar membrane) |
| 49 | Cd68 | Q4FZY1 | Cd68 molecule | NA | Specific GO (vacuolar membrane) |
| 50 | Slc39a14 | D3ZZM0 | Solute carrier family 39 (Zinc transporter), member 14 (Predicted) | NA | Specific GO (vacuolar membrane) |
| 51 | Atp5b | Q0QEP3 | ATP synthase, H+ transporting mitochondrial F1 complex, beta subunit | NA | Specific GO (cation channel activity) |
| 52 | Calhm5 | Q5FWS4 | Calcium homeostasis modulator family member 5 | NA | Specific GO (cation channel activity) |
| 53 | Cx43 | Connexin-43 | NA | Specific GO (cardiac conduction) | |
| 54 | Scn5a | Sodium channel subunit 5a | NA | Specific GO (cardiac conduction) | |
| 55 | cTnT | Cardiac troponin T | NA | Specific GO (cardiac conduction) | |
| 56 | Kcnh2 | hERG K channel | NA | Specific GO (cardiac conduction) | |
| 57 | Kcnd3 | Transient outward K channel | NA | Specific GO (cardiac conduction) | |
| 58 | Cacna1c | L-type Ca channel | NA | Specific GO (cardiac conduction) |
Figure 5Validation results of the candidate proteins. Changes in expression of each protein by radiation dose and timepoint. Comparison was done within each validation method. (A) Gsta1 (B) Ephx1 (C) Myot (D) Capg. Relative amount is a value of log2 normalized quantified in profiling and DIA method. *P < 0.05, **P < 0.01, ***P < 0.001.